<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Gisha;
panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:10.0pt;
margin-left:.5in;
line-height:115%;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Gisha","sans-serif";
color:windowtext;}
span.apple-converted-space
{mso-style-name:apple-converted-space;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:713433259;
mso-list-type:hybrid;
mso-list-template-ids:309234382 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1
{mso-list-id:1849442793;
mso-list-template-ids:-1682643730;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l1:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="2050" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal>Just a reminder that the Product Stewardship Institute (PSI) is holding <a href="http://www.productstewardship.us/event/on-the-road-after-the-alameda-decision">a <b>free</b> webinar</a> <b>tomorrow, June 9<sup>th</sup> from 2-3:30pm EDT</b>, to help those interested in extended producer responsibility for drug take-back programs understand the implications of the May 26<sup>th</sup> Supreme Court decision.<o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:white'><tr><td valign=top style='padding:2.25pt 15.75pt 0in 15.75pt'><p class=MsoNormal><strong><span style='font-size:18.0pt;font-family:"Calibri","sans-serif";color:#333333'>What this webinar is about…</span></strong><span style='font-size:18.0pt;color:#333333'><o:p></o:p></span></p></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:white;orphans: auto;widows: 1;-webkit-text-stroke-width: 0px;word-spacing:0px'><tr style='height:.75pt'><td valign=top style='padding:0in 0in 13.5pt 0in;height:.75pt'><p class=MsoNormal align=center style='text-align:center;mso-line-height-alt:.75pt'><span style='font-size:13.5pt;color:black'><img border=0 width=5 height=1 id="Picture_x0020_1" src="cid:image001.png@01D0A209.2311D140" alt="https://imgssl.constantcontact.com/letters/images/1101116784221/S.gif"></span><span style='font-size:13.5pt;color:black'><o:p></o:p></span></p></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="99%" style='width:99.58%;background:white;orphans: auto;widows: 1;-webkit-text-stroke-width: 0px;display:table;word-spacing:0px' id="content_LETTER.BLOCK15"><tr style='height:229.55pt'><td valign=top style='padding:3.75pt 15.75pt 11.25pt 15.75pt;height:229.55pt'><p style='margin:0in;margin-bottom:.0001pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>Two weeks ago, the Supreme Court <strong><span style='font-family:"Calibri","sans-serif"'>declined to hear</span></strong> Big Pharma’s petition against the Alameda County drug take-back ordinance, paving the way for similar EPR legislation around the country. In this webinar, our expert speakers will explore the<strong><span style='font-family:"Calibri","sans-serif"'> legal and technical </span></strong>aspects of this decision, and the effect it will have on <strong><span style='font-family:"Calibri","sans-serif"'>state and local governments, </span></strong>and other stakeholders. We will cover:<o:p></o:p></span></p><ul type=disc><li class=MsoNormal style='color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l1 level1 lfo1'>The origins of Alameda County’s interest in developing a take-back law, and the actions taken to build a coalition for passage;<o:p></o:p></li><li class=MsoNormal style='color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l1 level1 lfo1'>The current status of Alameda County’s drug take-back program implementation;<o:p></o:p></li><li class=MsoNormal style='color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l1 level1 lfo1'>The basis for the challenge to the Alameda County ordinance, and<span class=apple-converted-space> </span>the likely reasons<span class=apple-converted-space> </span>the Supreme Court<span class=apple-converted-space> </span>decided in favor of the county; <o:p></o:p></li><li class=MsoNormal style='color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l1 level1 lfo1'>How to write pharmaceutical take-back legislation to<span class=apple-converted-space> </span>minimize<span class=apple-converted-space> </span>the risk of future litigation; and <o:p></o:p></li><li class=MsoNormal style='color:black;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l1 level1 lfo1'>How litigation risk varies among circuit jurisdictions around the nation.<o:p></o:p></li></ul><p class=MsoNormal><span style='color:black'>There will be an extended Q&A session following the presentations.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p> </o:p></span></p><p class=MsoNormal><strong><span style='font-size:18.0pt;font-family:"Calibri","sans-serif";color:#333333'>Speakers include… <o:p></o:p></span></strong></p><p class=MsoNormal><strong><span style='font-size:18.0pt;font-family:"Calibri","sans-serif";color:#333333'><o:p> </o:p></span></strong></p><p class=MsoListParagraph style='margin-bottom:0in;margin-bottom:.0001pt;text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol;color:black'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span style='color:black'>Jayni Foley Hein, J.D. | Policy Director, <a href="http://policyintegrity.org/">Institute for Policy Integrity, NYU School of Law</a><o:p></o:p></span></p><p class=MsoListParagraph style='margin-bottom:0in;margin-bottom:.0001pt;text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol;color:black'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span style='color:black'>Dr. Joel Kreisberg, DC, CCH, ACC | Executive Director, <a href="http://www.teleosis.org/">Teleosis Institute</a><o:p></o:p></span></p><p class=MsoListParagraph style='margin-bottom:0in;margin-bottom:.0001pt;text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol;color:black'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span style='color:black'>Ed Gottlieb | Chair, <a href="http://www.healthyyouth.org/medication-disposal.php">Coalition for Safe Medication Disposal</a><o:p></o:p></span></p><p class=MsoListParagraph style='margin-bottom:0in;margin-bottom:.0001pt;text-indent:-.25in;mso-list:l0 level1 lfo2'><![if !supportLists]><span style='font-family:Symbol;color:black'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span style='color:black'>Scott Cassel | Chief Executive Officer and Founder, <a href="http://www.productstewardship.us/">Product Stewardship Institute</a> (Moderator) <o:p></o:p></span></p><p class=MsoNormal><span style='color:#B3AF3A'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='font-size:18.0pt;color:black'><a href="http://www.productstewardship.us/event/on-the-road-after-the-alameda-decision" target="_blank"><span style='color:#004DB4'>Register here for free</span></a>.</span></b><b><span style='font-size:18.0pt;color:black'><o:p></o:p></span></b></p></td></tr></table><p class=MsoNormal><span style='color:#7F7F7F'><o:p> </o:p></span></p><p class=MsoNormal>Thank you, and enjoy the webinar. <o:p></o:p></p><p class=MsoNormal>Waneta Trabert<span style='color:#7F7F7F'><o:p></o:p></span></p><p class=MsoNormal><span style='color:#7F7F7F'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='font-family:"Gisha","sans-serif";color:#7F7F7F'>_______________________________________<o:p></o:p></span></b></p><p class=MsoNormal><b><span style='font-family:"Gisha","sans-serif";color:#404040'>Waneta Trabert<o:p></o:p></span></b></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>Associate for Policy and Programs<o:p></o:p></span></p><p class=MsoNormal><i><span style='font-family:"Gisha","sans-serif";color:#404040'>Product Stewardship Institute, Inc.<o:p></o:p></span></i></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>29 Stanhope St., 3rd Floor, Boston, MA 02116<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>P: (617) 236-4866 F: (617) 236-4766<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>TTY: please use i711.com<o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>www.productstewardship.us <o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Gisha","sans-serif";color:#404040'>waneta@productstewardship.us <o:p></o:p></span></p><p class=MsoNormal><i><span style='font-size:8.0pt;font-family:"Gisha","sans-serif";color:#404040'>The Product Stewardship Institute, Inc. is an equal opportunity provider and employer.</span></i><i><span style='font-size:8.0pt;font-family:"Gisha","sans-serif";color:#7F7F7F'><o:p></o:p></span></i></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>